Vasoconstriction in exercising skeletal muscles: A potential role for neuropeptide Y?

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Buckwalter, John B ^a   Hamann, Jason J ^a   Kluess, Heidi A ^a   Clifford, Philip S ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autonomic nervous system; Blood flow; Dogs; Sympatholysis

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETERIZATION; ARTICLE; ATTENUATION; CONDUCTANCE; CONTROLLED STUDY; DOG; FEMORAL ARTERY; FLOW MEASUREMENT; HINDLIMB; HYPOTHESIS; MUSCLE EXERCISE; NEUROTRANSMITTER RELEASE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SKELETAL MUSCLE; SYMPATHETIC NERVE; VASOCONSTRICTION;

ANIMALS; DOGS; ENZYME INHIBITORS; MOTOR ACTIVITY; MUSCLE, SKELETAL; NEUROPEPTIDE Y; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTORS, NEUROPEPTIDE Y; REGIONAL BLOOD FLOW; VASOCONSTRICTION;

EID: 3042670441     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00071.2004     Document Type: Article

References (50)

1. Berglund MM, Hipskind PA, and Gehlert DR. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp Biol Med (Maywood) 228: 217-244, 2003.
2. Buckwalter JB and Clifford PS. The paradox of sympathetic vasoconstriction in exercising skeletal muscle. Exerc Sport Sci Rev 29: 159-163, 2001.
3. Buckwalter JB and Clifford PS. α-Adrenergic vasoconstriction in active skeletal muscles during dynamic exercise. Am J Physiol Heart Circ Physiol 277: H33-H39, 1999.
4. Buckwalter JB and Clifford PS. Autonomic influence on skeletal muscle blood flow at the onset of dynamic exercise. Am J Physiol Heart Circ Physiol 277: H1872-H1877, 1999.
5. Buckwalter JB, Hamann JJ, and Clifford PS. Vasoconstriction in active skeletal muscles: a potential role for P2X purinergic receptors? J Appl Physiol 95: 953-959, 2003.
6. 1- Adrenergic receptor responsiveness in skeletal muscle during dynamic exercise. J Appl Physiol 85: 2277-2283, 1998.
7. Buckwalter JB, Mueller PJ, and Clifford PS. Sympathetic vasoconstriction in active skeletal muscles during dynamic exercise. J Appl Physiol 83: 1575-1580, 1997.
8. Buckwalter JB, Naik JS, Valic Z, and Clifford PS. Exercise attenuates α-adrenergic receptor responsiveness in skeletal muscle vasculature. J Appl Physiol 90: 172-178, 2001.
9. Buckwalter JB, Ruble SB, Mueller PJ, and Clifford PS. Skeletal muscle vasodilation at the onset of exercise. J Appl Physiol 85: 1649-1654, 1998.
10. Buckwalter JB, Taylor JC, Hamann JJ, and Clifford PS. Do P2X purinergic receptors regulate skeletal muscle blood flow during exercise? Am J Physiol Heart Circ Physiol 286: H633-H639, 2004.
11. Chavoshan B, Sander M, Sybert TE, Victor RG, and Thomas GD. Nitric oxide-dependent modulation of sympathetic vasoconstriction in the microvasculature of exercising human skeletal muscle. J Physiol 540: 377-386, 2002.
12. Cooke JP, Shepherd JT, and Vanhoutte PM. The effect of warming on adrenergic neurotransmission in canine cutaneous vein. Circ Res 54: 547-553, 1984.
13. DiCarlo SE, Chen CY, and Collins HL. Onset of exercise increases lumbar sympathetic nerve activity in rats. Med Sci Sports Exerc 28: 677-684, 1996.
14. Dinenno FA and Joyner MJ. Blunted sympathetic vasoconstriction in contracting skeletal muscle of healthy humans: is nitric oxide obligatory? J Physiol 553: 281-292, 2003.
15. Faber JE. In situ analysis of α-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation. Circ Res 62: 37-50, 1988.
16. Hajduczok G, Hade JS, Mark AL, Williams JL, and Felder RB. Central command increases sympathetic nerve activity during spontaneous locomotion in cats. Circ Res 69: 66-75, 1991.
17. Hamann JJ, Buckwalter JB, Valic Z, and Clifford PS. Sympathetic restraint of muscle blood flow at the onset of dynamic exercise. J Appl Physiol 92: 2452-2456, 2002.
18. Hill JM, Adreani CM, and Kaufman MP. Muscle reflex stimulates sympathetic postganglionic efferents innervating triceps surae muscles of cats. Am J Physiol Heart Circ Physiol 271: H38-H43, 1996.
19. 2Y- purinoceptors in the isolated perfused rat heart. Eur J Pharmacol 136: 49-54, 1987.
20. Hu Y and Dunbar JC. Regional vascular cardiac responses to systemic neuropeptide-Y in normal and diabetic rats. Peptides 18: 809-815, 1997.
21. 2 uptake in rhythmically contracting human forearm muscles. Am J Physiol Heart Circ Physiol 263: H1078-H1083, 1992.
22. Kennedy C, Saville VL, and Burnstock G. The contributions of noradrenaline and ATP to the responses of the rabbit central ear artery to sympathetic nerve stimulation depend on the parameters of stimulation. Eur J Pharmacol 122: 291-300, 1986.
23. Klabunde RE. Attenuation of reactive and active hyperemia by sympathetic stimulation in dog gracilis muscle. Am J Physiol Heart Circ Physiol 251: H1183-H1187, 1986.
24. Lautt WW. Resistance or conductance for expression of arterial vascular tone. Microvasc Res 37: 230-236, 1989.
25. Lundberg JM, Martinsson A, Mensen A, Theodorsson-Norheim E, Svedenhag J, Ekblom B, and Hjemdahl P. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun 133: 30-36, 1985.
26. 1 receptor antagonist BIBP 3226. Br J Pharmacol 116: 2971-2982, 1995.
27. 2- adrenoceptors. Circ Res 66: 1643-1657, 1990.
28. 2-adrenoceptor constriction of rat skeletal muscle microvessels. Circ Res 69: 165-173, 1991.
29. Malmstrom RE, Bjorne H, Alving K, Weitzberg E, and Lundberg JON. Nitric oxide inhibition of renal vasoconstrictor responses to sympathetic cotransmitters in the pig in vivo. Nitric Oxide 5: 98-104, 2001.
30. Malmstrom RE, Hokfelt T, Bjorkman JA, Nehlen C, Bystrom M, Ekstrand AJ, and Lundberg JM. Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog. Regul Pept 75-76: 55-70, 1998.
31. 2-adrenoceptor-mediated vasoconstrictor responses in isolated arteries. Eur J Pharmacol 135: 443-447, 1987.
32. Meier MA and Long DM. Carotid artery loop for repeated catheterization of the left ventricle in dogs. Surgery 70: 797-799, 1971.
33. Nilsson T, Hrafnkelsdottier T, Edvinsson L, Jern S, Erlinge D, and Wall U. Forearm blood flow responses to neuropeptide Y, noradrenaline and adenosine 5-triphosphate in hypertensive and normotensive subjects. Blood Press 9: 126-131, 2000.
34. O'Brien DJ, Chapman WH, Rudd FV, and McRoberts JW. Carotid artery loop method of blood pressure measurement in the dog. J Appl Physiol 30: 161-163, 1971.
35. O'Hagan KP, Bell LB, Mittelstadt SW, and Clifford PS. Effect of dynamic exercise on renal sympathetic nerve activity in conscious rabbits. J Appl Physiol 74: 2099-2104, 1993.
36. O'Leary DS, Robinson ED, and Butler JL. Is active skeletal muscle functionally vasoconstricted during dynamic exercise in conscious dogs? Am J Physiol Regul Integr Comp Physiol 272: R386-R391, 1997.
37. Pernow J, Kahan T, Hjemdahl P, and Lundberg JM. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle. Acta Physiol Scand 132: 43-50, 1988.
38. Pernow J, Lundberg JM, Kaijser L, Hjemdahl P, Theodorsson-Norheim E, Martinsson A, and Pernow B. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol 6: 561-578, 1986.
39. Pernow J, Ohlen A, Hokfelt T, Nilsson O, and Lundberg JM. Neuropeptide Y: presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man. Regul Pept 19: 313-324, 1987.
40. Remensnyder JP, Mitchell JH, and Sarnoff SJ. Functional sympatholysis during muscular activity. Circ Res 11: 370-380, 1962.
41. 2-adrenergic vasoconstriction is blunted in contracting human muscle. J Physiol 547: 971-976, 2003.
42. Rowell LB. Human Cardiovascular Control. New York: Oxford University Press, 1993.
43. Ruble SB, Valic Z, Buckwalter JB, and Clifford PS. Dynamic exercise attenuates sympathetic responsiveness of canine vascular smooth muscle. J Appl Physiol 89: 2294-2299, 2000.
44. Ruble SB, Valic Z, Buckwalter JB, Tschakovsky ME, and Clifford PS. Attenuated vascular responsiveness to norepinephrine release during dynamic exercise in dogs. J Physiol 541: 637-644, 2002.
45. Sander M, Chavoshan B, Harris SA, Iannoccone ST, Stull JT, Thomas GD, and Victor RG. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci USA 97: 13818-13823, 2000.
46. 1-adrenoceptor constriction by acidosis and hypoxia in vitro. Am J Physiol Heart Circ Physiol 268: H2068-H2076, 1995.
47. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, and Victor RG. Impaired metabolic modulation of α-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci USA 95: 15090-15095, 1998.
48. Thomas GD and Victor RG. Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Physiol 506: 817-826, 1997.
49. Tschakovsky ME, Sujirattanawimol K, Ruble SB, Valic Z, and Joyner MJ. Is sympathetic neural vasocoastriction blunted in the vascular bed of exercising human muscle? J Physiol 541: 623-635, 2002.
50. Wahlestedt C, Yanaihara N, and Hakanson R. Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept 13: 307-318, 1986.